Daniel Carlson

1730 POSTS 436 COMMENTS

Front Page

Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating...

Daniel Carlson - July 29, 2021

Front Page

INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimer’s Disease...

Daniel Carlson - July 26, 2021

Anixa

July About to Close With a Bang?

Daniel Carlson - July 24, 2021

Front Page

ParkerVision Receives Second Favorable Markman Ruling in ParkerVision v. Intel

Daniel Carlson - July 23, 2021

Front Page

Lantern Pharma Announces Significant Positive Preclinical Data in Pancreatic Cancer With...

Daniel Carlson - July 20, 2021

Front Page

INmune Bio, Inc. Announces Poster Presentation and Plenary Talk at the...

Daniel Carlson - July 19, 2021

Anixa

Back In The Torture Chamber

Daniel Carlson - July 17, 2021

Front Page

INmune Bio, Inc. Announces $40 Million Registered Direct Offering

Daniel Carlson - July 14, 2021

Front Page

TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its...

Daniel Carlson - July 13, 2021

Front Page

INmune Bio, Inc. Announces First Patient Treated with NK cell priming...

Daniel Carlson - July 12, 2021

Front Page

Kentucky Bluegrass

Daniel Carlson - July 10, 2021

Front Page

LexaGene Launches 2nd Generation Bacterial and Drug Resistance Test to Better...

Daniel Carlson - July 7, 2021

Anixa

Let’s Get Ready To Rumble (2nd Half Preview)

Daniel Carlson - July 3, 2021

Front Page

LexaGene Advances Towards FDA Emergency Use Authorization

Daniel Carlson - July 2, 2021

Fortress Bio

Journey Medical Corporation Enters into a Definitive Agreement with Dr. Reddy’s...

Daniel Carlson - June 30, 2021

Amryt

Hoping for Fireworks

Daniel Carlson - June 26, 2021

Front Page

Trading Blog, June 24, 2021

Daniel Carlson - June 24, 2021

Front Page

Augmenta Bioworks and TFF Pharmaceuticals Announce Selection of Lead Monoclonal Antibody...

Daniel Carlson - June 22, 2021

Front Page

Put The Hammer Down…Backgammon Lessons

Daniel Carlson - June 19, 2021

Front Page

LexaGene’s MiQLab Offers Rapid Plague Detection for Bioterrorism Threats

Daniel Carlson - June 17, 2021

Front Page

Warrant Repo Is A Coup For INmune

Daniel Carlson - June 15, 2021

Front Page

INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor...

Daniel Carlson - June 15, 2021

Front Page

QUEST RESOURCE HOLDING CORPORATION ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE ASSET-LIGHT WASTE...

Daniel Carlson - June 15, 2021

Front Page

LexaGene Closes Sale to Alpine Veterinary Hospital

Daniel Carlson - June 14, 2021

Amryt

Stock Picking Wins This Week

Daniel Carlson - June 12, 2021

Fortress Bio

Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and...

Daniel Carlson - June 11, 2021

$Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted CAR T in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia$

Fortress Bio

Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted...

Daniel Carlson - June 11, 2021

Front Page

LexaGene detects a slow-growing bacterium at least 36-times faster than conventional...

Daniel Carlson - June 10, 2021

Front Page

Aducanumab Approval…Implications For INmune Bio

Daniel Carlson - June 8, 2021

Front Page

LexaGene Sells a MiQLab System to Denver Animal Emergency

Daniel Carlson - June 7, 2021

Front Page

TFF Pharmaceuticals Hosting Key Opinion Leader Perspectives on Thin Film Freezing...

Daniel Carlson - June 7, 2021

Amryt

FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee...

Daniel Carlson - June 7, 2021

Amryt

Oregon Trails

Daniel Carlson - June 4, 2021

Front Page

LexaGene Partners with Ethos Discovery to Develop New Companion Animal Diagnostic...

Daniel Carlson - June 3, 2021

Amryt

FDA Grants Priority Review for New Drug Application for Oleogel-S10 for...

Daniel Carlson - June 3, 2021

Front Page

INmune Bio, Inc. Announces Lead Drug Candidate XPro1595 Receives Chemical Drug...

Daniel Carlson - June 2, 2021

Amryt

Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for...

Daniel Carlson - June 2, 2021

Front Page

LexaGene Takes Steps to List on the Nasdaq

Daniel Carlson - June 1, 2021

Atomera

Resetting Expectations for TFF Pharma

Daniel Carlson - May 28, 2021

Anixa

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian...

Daniel Carlson - May 26, 2021

Front Page

ParkerVision Files Against LG for Patent Infringement

Daniel Carlson - May 24, 2021

Front Page

Reversal of Fortune

Daniel Carlson - May 22, 2021

Anixa

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from...

Daniel Carlson - May 20, 2021

Front Page

ParkerVision Secures Patent License and Settlement Agreement with Buffalo, Inc.

Daniel Carlson - May 19, 2021

Front Page

Quest Resource Holding Corporation Reports First Quarter 2021 Financial Results

Daniel Carlson - May 18, 2021

Fortress Bio

Mustang Bio and City of Hope Announce First Patient Dosed in...

Daniel Carlson - May 18, 2021

Fortress Bio

Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate...

Daniel Carlson - May 17, 2021

Anixa

Gas Lines and Inflation…Is This The 80’s?

Daniel Carlson - May 15, 2021

Front Page

TFF Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business...

Daniel Carlson - May 13, 2021

Amryt

Opportunity Knocks, Amryt Smartly Acquires Chiasma

Daniel Carlson - May 12, 2021

Front Page

Summit Wireless Technologies Posts 181% Q1 2021 Revenue Increase and Guides...

Daniel Carlson - May 12, 2021

Fortress Bio

Checkpoint Therapeutics Announces Completion of Enrollment in the Registration-Enabling Trial of...

Daniel Carlson - May 12, 2021

Fortress Bio

Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop...

Daniel Carlson - May 11, 2021

Front Page

LexaGene Expands Its Sales Team

Daniel Carlson - May 11, 2021

Amryt

The Beatings Will Continue Until Morale Improves…

Daniel Carlson - May 7, 2021

Anixa

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

Daniel Carlson - May 7, 2021

Front Page

INmune Bio, Inc. Announces First Quarter 2021 Results and Provides Business...

Daniel Carlson - May 5, 2021

Amryt

Amryt Reports Record Q1 2021 Financial and Operating Results

Daniel Carlson - May 5, 2021

Amryt

Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership...

Daniel Carlson - May 5, 2021

Front Page

Lantern Shines During Biotech Blackout

Daniel Carlson - May 4, 2021

Front Page

Lantern Pharma Reports First Quarter 2021 Financial Results and Operational Highlights

Daniel Carlson - May 3, 2021

Front Page

Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging...

Daniel Carlson - May 3, 2021

Anixa

Alpha-Bet Soup

Daniel Carlson - May 1, 2021

Front Page

Trading Blog, April 30, 2021

Daniel Carlson - April 30, 2021

Front Page

Trade Alert, April 29th, 2021

Daniel Carlson - April 29, 2021

Front Page

QUEST® PROGANICS™ PROVIDES A TRANSFORMATIVE STEP FORWARD IN ORGANICS RECYCLING

Daniel Carlson - April 29, 2021

Front Page

Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®,...

Daniel Carlson - April 29, 2021

Front Page

Trading Blog, April 27th

Daniel Carlson - April 27, 2021

Front Page

Sequans Communications Announces First Quarter 2021 Financial Results

Daniel Carlson - April 27, 2021

Front Page

Lantern Pharma Announces Publication Detailing Preclinical Results of Drug Candidate, LP-184,...

Daniel Carlson - April 26, 2021

Anixa

The Lows Appear To Be In Place

Daniel Carlson - April 24, 2021

Front Page

Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa Presents VenoValve One...

Daniel Carlson - April 23, 2021

Front Page

XPro1595: A Next-Generation TNF Inhibitor

Daniel Carlson - April 21, 2021

Anixa

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of...

Daniel Carlson - April 19, 2021

Anixa

How Long Can You Hold A Soccer Ball Under Water?

Daniel Carlson - April 17, 2021

Atomera

Atomera Appoints Sudarsan Srinivasan as Vice President of Engineering

Daniel Carlson - April 14, 2021

Front Page

LEXAGENE HOSTS A SEMINAR TO PRESENT MIQLAB DATA FROM VETERINARY SAMPLES

Daniel Carlson - April 14, 2021

Front Page

TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program...

Daniel Carlson - April 13, 2021

Front Page

In Defense of INmune

Daniel Carlson - April 10, 2021

Front Page

First U.S. Patent Issues on Hancock Jaffe VenoValve

Daniel Carlson - April 7, 2021

Front Page

Sequans Announces $50 Million Financing to Strengthen Balance Sheet

Daniel Carlson - April 7, 2021

Front Page

Lithe Audio Launches First WiSA Certified Dolby Atmos Ceiling Speakers

Daniel Carlson - April 7, 2021

Amryt

Amryt Announces the Appointment of Sheila Frame as President Americas

Daniel Carlson - April 6, 2021

Front Page

Trading Blog, April 6, 2021

Daniel Carlson - April 6, 2021

Anixa

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19...

Daniel Carlson - April 5, 2021

Front Page

Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Pivotal Trial

Daniel Carlson - April 5, 2021

Amryt

A Catalyst Filled Quarter Lies Around The Corner

Daniel Carlson - April 3, 2021

Fortress Bio

Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc.,...

Daniel Carlson - April 1, 2021

Front Page

LEXAGENE PROVIDES CORPORATE UPDATE

Daniel Carlson - April 1, 2021

Front Page

Lantern Pharma Expands Portfolio of Cancer Opportunities for LP-184 with ATRT...

Daniel Carlson - April 1, 2021

Amryt

Amryt Submits a New Drug Application to the US Food and...

Daniel Carlson - March 31, 2021

Amryt

Amryt Announces Results from an Investigator Sponsored Study of Lomitapide in...

Daniel Carlson - March 30, 2021

Front Page

Orlando Court to Reschedule Trial; Company Raises $3.6 Million in Private...

Daniel Carlson - March 29, 2021

Amryt

Amryt Announces Validation of its MAA by the EMA for Oleogel-S10*...

Daniel Carlson - March 29, 2021

Anixa

2nd Degree of Risk

Daniel Carlson - March 27, 2021

Front Page

TFF Pharmaceuticals Prices Offering of Common Stock

Daniel Carlson - March 26, 2021

Anixa

This Week’s View On Anixa

Daniel Carlson - March 25, 2021

Uncategorized

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock...

Daniel Carlson - March 23, 2021

Front Page

WiSA Member Foxconn Demos Sharp 120-Inch 8K TV with WiSA SoundSend...

Daniel Carlson - March 23, 2021

Amryt

Amryt Receives Positive Feedback from the FDA on the Path Forward...

Daniel Carlson - March 23, 2021

Front Page

Lantern Pharma to Present New Data Supporting the Advancement of LP-184...

Daniel Carlson - March 23, 2021

Anixa

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian...

Daniel Carlson - March 22, 2021

Amryt

Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs...

Daniel Carlson - March 22, 2021

Anixa

Sitting On My Hands

Daniel Carlson - March 20, 2021

Front Page

Hisense TVs Certified WiSA Ready™, WiSA’s Interoperability Standard Becoming Must-Have Feature...

Daniel Carlson - March 18, 2021

Front Page

Lantern Pharma Announces Filing of Seven Patent Applications Globally on Novel...

Daniel Carlson - March 17, 2021

Anixa

Technically Speaking

Daniel Carlson - March 13, 2021

Front Page

Recapping TFF’s Shareholder Update Call

Daniel Carlson - March 12, 2021

Front Page

QUEST RESOURCE HOLDING CORPORATION REPORTS 2020 FINANCIAL RESULTS

Daniel Carlson - March 12, 2021

Anixa

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian...

Daniel Carlson - March 12, 2021

Front Page

Platin Audio Debuts Sleek and Powerful New Product Line for Home...

Daniel Carlson - March 11, 2021

Front Page

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and...

Daniel Carlson - March 10, 2021

Front Page

Lantern Pharma Reports Fourth Quarter and Year End 2020 Financial Results...

Daniel Carlson - March 10, 2021

Front Page

NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration

Daniel Carlson - March 9, 2021

Front Page

Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine...

Daniel Carlson - March 9, 2021

Front Page

Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results

Daniel Carlson - March 8, 2021

Amryt

Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in...

Daniel Carlson - March 8, 2021

Amryt

Blood In The Water

Daniel Carlson - March 6, 2021

Front Page

Trading Blog, March 5, 2021

Daniel Carlson - March 5, 2021

Anixa

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

Daniel Carlson - March 4, 2021

Front Page

TFF Pharmaceuticals Provides Update on Clinical Development Programs

Daniel Carlson - March 4, 2021

Amryt

Amryt (AMYT): A Rare Find in Today’s Market… Growth At A...

Daniel Carlson - March 2, 2021

Front Page

LEXAGENE RECEIVES $3.6M FROM THE EXERCISE OF WARRANTS

Daniel Carlson - March 2, 2021

Atomera

Atomera, Inc: Atomera Announces First Customer to Enter Phase 4

Daniel Carlson - March 2, 2021

Front Page

Keep Looking Forward

Daniel Carlson - February 27, 2021

Fortress Bio

Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer

Daniel Carlson - February 25, 2021

Front Page

Trading Blog, Feb. 25th 2021

Daniel Carlson - February 25, 2021

Fortress Bio

Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a...

Daniel Carlson - February 24, 2021

Front Page

Miami Advice

Daniel Carlson - February 20, 2021

Front Page

TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for...

Daniel Carlson - February 19, 2021

Front Page

Trading Blog, Feb. 18th, 2021

Daniel Carlson - February 16, 2021

Anixa

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

Daniel Carlson - February 16, 2021

Anixa

Heard On The Street

Daniel Carlson - February 13, 2021

Front Page

LexaGene Announces Change in Management and Appoints New Member to the...

Daniel Carlson - February 12, 2021

Front Page

HJLI Tried To Ruin 2019 For Me…2021 Should Be A Different...

Daniel Carlson - February 10, 2021

Atomera

Atomera Provides Fourth Quarter and Fiscal 2020 Results

Daniel Carlson - February 10, 2021

Front Page

LEXAGENE’S MIQLAB SUCCESSFULLY DETECTS MUTANT UK AND SOUTH AFRICAN COVID-19 SEQUENCES

Daniel Carlson - February 10, 2021

Front Page

Sequans Communications Announces Fourth Quarter 2020 and Full Year 2020 Financial...

Daniel Carlson - February 10, 2021

Anixa

Riding the Waves

Daniel Carlson - February 6, 2021

INmune

Trading Blog: INmune (INMB) and Cassava (SAVA)

Daniel Carlson - February 2, 2021

Fortress Bio

Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the...

Daniel Carlson - February 2, 2021

Anixa

The GameStop Impact…January In Review

Daniel Carlson - January 30, 2021

Front Page

Sequans Receives Major Funding Award for 5G Development From French Government

Daniel Carlson - January 28, 2021

Front Page

ParkerVision Gets Inside Track On Intel In Markman Ruling

Daniel Carlson - January 27, 2021

Front Page

Trading Blog, Jan. 26, 2021

Daniel Carlson - January 27, 2021

Front Page

Texas Court’s Markman Ruling Favorable for ParkerVision

Daniel Carlson - January 27, 2021

Front Page

When Will The Music Stop?

Daniel Carlson - January 23, 2021

Front Page

INmune…Meaningful Progress in Alzheimer’s Disease

Daniel Carlson - January 21, 2021

Front Page

INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration...

Daniel Carlson - January 21, 2021

Front Page

Trade Alert, January 20, 2020

Daniel Carlson - January 20, 2021

Atomera

Next Up? INmune’s Big Week Finally Arrives

Daniel Carlson - January 16, 2021

Front Page

Lantern Pharma Announces Pricing of $60 Million Public Offering

Daniel Carlson - January 15, 2021

Front Page

Summit Wireless Technologies Reports Record Preliminary Revenue of $1.0 Million in...

Daniel Carlson - January 14, 2021

Front Page

LLY’s $20 Billion Bonanza Bodes Well For INMB

Daniel Carlson - January 13, 2021

Front Page

Provention Bio Announces Pricing of $100 Million Public Offering of Common...

Daniel Carlson - January 13, 2021

Front Page

LEXAGENE INITIATES PROGRAM TO IDENTIFY UK AND SOUTH AFRICAN COVID SEQUENCES

Daniel Carlson - January 13, 2021

Front Page

INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday,...

Daniel Carlson - January 13, 2021

Front Page

Trading Blog, Jan. 12, 2021

Daniel Carlson - January 12, 2021

Front Page

Muscle Maker Grill Opens Second Ghost Kitchen Location in Philadelphia

Daniel Carlson - January 12, 2021

Front Page

WiSA Wave Marketing Program Results in Record Consumer Traffic and is...

Daniel Carlson - January 12, 2021

Anixa

BOOM…Atomera Deal Highlights Another Bull Ride In The Market

Daniel Carlson - January 9, 2021

Front Page

Renesas and Sequans Expand Their 5G Collaboration Broadband IoT Module for...

Daniel Carlson - January 8, 2021

Front Page

First Complete Home Cinema Bundles with Hisense TVs, WiSA SoundSend Wireless...

Daniel Carlson - January 8, 2021

Atomera

ATOM: FOMO Kept Me From Selling, But Is It A Buy?

Daniel Carlson - January 7, 2021

Front Page

Trading Blog, January 7, 2021

Daniel Carlson - January 7, 2021

Front Page

Summit Wireless Technologies Launches the First Low-cost IoT Module to Support...

Daniel Carlson - January 6, 2021

Atomera

Atomera Inks First JDA

Daniel Carlson - January 5, 2021

Front Page

Lantern Pharma Announces Launch of Antibody Drug Conjugate (ADC) Program to...

Daniel Carlson - January 4, 2021

Front Page

Provention Bio Announces U.S. FDA Filing of a Biologics License Application...

Daniel Carlson - January 4, 2021

Front Page

TW’s Top Ten For 2021

Daniel Carlson - January 1, 2021

Front Page

Muscle Maker Grill Opens the Doors to Their First Ghost Kitchen...

Daniel Carlson - January 1, 2021

Front Page

Premium Subscriber Trade Alert, December 31, 2020

Daniel Carlson - January 1, 2021

Front Page

LEXAGENE STARTS FDA EUA STUDY FOR POINT-OF-CARE COVID-19 TESTING

Daniel Carlson - December 30, 2020

Anixa

Ho Ho Ho, Santa Rally Caps Bizarre Year

Daniel Carlson - December 26, 2020

Front Page

Trading Blog, December 21, 2020

Daniel Carlson - December 21, 2020

Fortress Bio

Mustang Bio and City of Hope Announce Initiation of Phase 1...

Daniel Carlson - December 21, 2020

Anixa

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical...

Daniel Carlson - December 21, 2020

Atomera

The Squeeze Is On

Daniel Carlson - December 18, 2020

Front Page

Trading Blog, December 18, 2020

Daniel Carlson - December 18, 2020

Front Page

Put LP-184, a Potential Blockbuster in the Making, on Your Radar...

Daniel Carlson - December 18, 2020

Front Page

LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency...

Daniel Carlson - December 17, 2020

Front Page

Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at...

Daniel Carlson - December 17, 2020

Fortress Bio

Avenue Therapeutics Provides Regulatory Update for IV Tramadol

Daniel Carlson - December 17, 2020

Fortress Bio

Fortress Biotech Announces Breakthrough Therapy Designation for CUTX-101, Copper Histidinate, for...

Daniel Carlson - December 15, 2020

Front Page

TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation...

Daniel Carlson - December 15, 2020

Front Page

LexaGene Receives Purchase Order for MiQLab from Ethos Discovery

Daniel Carlson - December 15, 2020

Front Page

Lantern Pharma Announces Scientific & Preclinical Data Indicating Blood Brain Barrier...

Daniel Carlson - December 15, 2020

Front Page

Trade Alert, Dec. 14th, 2020

Daniel Carlson - December 14, 2020

Anixa

Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical...

Daniel Carlson - December 14, 2020

$Mustang Bio Announces Interim Phase 1/2 Data for MB-106 in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma$

Fortress Bio

Mustang Bio Announces Interim Phase 1/2 Data for MB-106 in Patients...

Daniel Carlson - December 12, 2020

Front Page

Changes at TW

Daniel Carlson - December 12, 2020

Anixa

Climbing The Wall Of Worry…

Daniel Carlson - December 12, 2020

Front Page

Sequans’ Monarch Module supported by Orange LTE-M Connectivity Now Available

Daniel Carlson - December 10, 2020

Front Page

Muscle Maker Grill Opens First Partnership Location with REEF Neighborhood Kitchens...

Daniel Carlson - December 9, 2020

Front Page

JDRF Launches First Mass Screening Program for Early-Stage Type 1 Diabetes...

Daniel Carlson - December 8, 2020

Atomera

Atomera Announces Availability of MSTcad for Modeling Semiconductor Device Improvements with...

Daniel Carlson - December 8, 2020

Front Page

SQNS Announces Pricing of Public Secondary Offering of American Depositary Shares

Daniel Carlson - December 8, 2020

Front Page

Aptose Presents Highlights from ASH and Corporate Update Event

Daniel Carlson - December 6, 2020

Anixa

The Micro-Cap Rally Continues Full Force

Daniel Carlson - December 5, 2020

Front Page

Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia...

Daniel Carlson - December 3, 2020

Front Page

Timing Looks Good For Owning Aptose (APTO)

Daniel Carlson - December 3, 2020

Anixa

Anixa Adds An Ovarian Cancer Vaccine To Their Portfolio

Daniel Carlson - December 1, 2020

Anixa

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer...

Daniel Carlson - December 1, 2020

Front Page

WiSA’s First Branded Product, SoundSend, Now Available for WiSA Partners, Distributors...

Daniel Carlson - November 30, 2020

Anixa

Timing Is Everything…Or Is It?

Daniel Carlson - November 28, 2020

Fortress Bio

Mustang Bio Announces Positive Opinion from the European Medicines Agency on...

Daniel Carlson - November 24, 2020

Anixa

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer...

Daniel Carlson - November 23, 2020

Fortress Bio

Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP...

Daniel Carlson - November 23, 2020

Front Page

A Micro Thanksgiving

Daniel Carlson - November 21, 2020

Front Page

Trading Ideas Heading Towards Year-End

Daniel Carlson - November 19, 2020

Front Page

LEXAGENE PLACES MIQLAB SYSTEM AT THE UNIVERSITY OF PENNSYLVANIA’S SCHOOL OF...

Daniel Carlson - November 18, 2020

Front Page

Lantern Pharma Earnings Call Transcript

Daniel Carlson - November 17, 2020

Uncategorized

QUEST RESOURCE HOLDING REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS

Daniel Carlson - November 16, 2020

Front Page

Processa Pharmaceuticas Transcript

Daniel Carlson - November 16, 2020

Front Page

LEXAGENE RECEIVES PURCHASE ORDER FROM A MULTINATIONAL BIOTECHNOLOGY COMPANY

Daniel Carlson - November 16, 2020

Anixa

The Biden Rally

Daniel Carlson - November 14, 2020

Front Page

Harrow Health Third Quarter 2020 Letter to Stockholders

Daniel Carlson - November 10, 2020

Front Page

Pfizer Develops a Vaccine…Implications for Tailwinds

Daniel Carlson - November 10, 2020

Front Page

ParkerVision Files Against Zyxel and Buffalo for Patent Infringement

Daniel Carlson - November 10, 2020

Front Page

Summit Wireless Technologies Gains Momentum and Provides Third Quarter 2020 Update

Daniel Carlson - November 10, 2020

Fortress Bio

Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at...

Daniel Carlson - November 9, 2020

Front Page

INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial...

Daniel Carlson - November 9, 2020

Fortress Bio

Moving Week

Daniel Carlson - November 7, 2020

Front Page

TFFP, INMB, OTRK…Earnings Logjam At Tailwinds

Daniel Carlson - November 6, 2020

Front Page

INmune Bio, Inc. Announces Third Quarter Results and Provides Business Update

Daniel Carlson - November 5, 2020

Front Page

TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results

Daniel Carlson - November 5, 2020

Front Page

TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a...

Daniel Carlson - November 5, 2020

Front Page

WiSA Association Expands TV Brand Member List With Rapidly Growing Hisense

Daniel Carlson - November 5, 2020

Fortress Bio

Mustang Bio Announces MB-106 Data Selected for Presentation at the 62nd...

Daniel Carlson - November 4, 2020

Front Page

Provention Bio Completes Rolling Submission of the Biologics License Application (BLA)...

Daniel Carlson - November 2, 2020

Front Page

TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide...

Daniel Carlson - November 2, 2020

Anixa

Sell Mortimer, Sell!!!

Daniel Carlson - October 31, 2020

Atomera

Atomera Provides Third Quarter 2020 Results

Daniel Carlson - October 29, 2020

Front Page

Lantern Pharma Reports Third Quarter 2020 Financial Results & Continued Operational...

Daniel Carlson - October 29, 2020

Front Page

Buoyed by the Boom in New Home Theaters, WiSA Member Platin...

Daniel Carlson - October 28, 2020

Anixa

Anixa Biosciences to Host Conference Call to Provide Update on Programs

Daniel Carlson - October 27, 2020

Front Page

Muscle Maker Grill Adds Three New Ghost Kitchen Markets

Daniel Carlson - October 27, 2020

Front Page

Sequans Communications Announces Third Quarter 2020 Financial Results

Daniel Carlson - October 27, 2020

Front Page

TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal...

Daniel Carlson - October 27, 2020

Fortress Bio

Mustang Bio Announces Initial Phase 1 Data on MB-105 for Patients...

Daniel Carlson - October 26, 2020

Front Page

TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with Experic

Daniel Carlson - October 26, 2020

Fortress Bio

Time for Small Cap to Shine?

Daniel Carlson - October 24, 2020

Front Page

Muscle Maker Grill Acquires Manhattan Location

Daniel Carlson - October 23, 2020

Front Page

Pharmaceutics: Development of Remdesivir as a Dry Powder for Inhalation by...

Daniel Carlson - October 23, 2020

Front Page

Muscle Maker Grill Signs Agreement Bringing Ghost Kitchens to Miami Beach,...

Daniel Carlson - October 22, 2020

Front Page

Renesas and Sequans to Collaborate on 5G/4G Cellular IoT

Daniel Carlson - October 22, 2020

Front Page

Muscle Maker Grill Awarded Contract for Two Locations on Navy Base

Daniel Carlson - October 21, 2020

Front Page

TFF Firing on All Cylinders; An Update on TAC and CBD

Daniel Carlson - October 21, 2020

Front Page

QUEST RESOURCE HOLDING CORPORATION ACQUIRES GREEN REMEDIES, STRENGTHENING PRESENCE IN STRATEGIC...

Daniel Carlson - October 20, 2020

Front Page

TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation...

Daniel Carlson - October 20, 2020

Front Page

CABRAL GOLD IDENTIFIES NEW HIGH-GRADE TARGET AND PROVIDES RESULTS ON THE...

Daniel Carlson - October 20, 2020

Anixa

Post Traumatic Investment Disease Redux? Nah, Just A Dose Of Reality

Daniel Carlson - October 17, 2020

Front Page

Muscle Maker Grill Provides Shareholder Update

Daniel Carlson - October 15, 2020

Front Page

Trade Alert, October 12, 2020

Daniel Carlson - October 12, 2020

Front Page

Dyadic Updates Market on COVID-19 Initiatives

Daniel Carlson - October 12, 2020

Fortress Bio

Avenue Therapeutics Receives Complete Response Letter from the FDA for IV...

Daniel Carlson - October 12, 2020

Anixa

This Week In Moab

Daniel Carlson - October 9, 2020

Front Page

Consumer Interest in WiSA Continues its Strong Upward Trajectory

Daniel Carlson - October 8, 2020

Fortress Bio

Mustang Bio Announces MB-105 Data Selected for Presentation at the Virtual...

Daniel Carlson - October 8, 2020

Front Page

Muscle Maker Grill Announces Opening of Healthy Joe’s in NYC

Daniel Carlson - October 7, 2020

Front Page

Telit and Sequans Partner to Launch New CBRS Modules

Daniel Carlson - October 5, 2020

Front Page

Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown...

Daniel Carlson - October 5, 2020

Front Page

LexaGene Provides a Corporate Update

Daniel Carlson - October 5, 2020

Anixa

The Final Push…

Daniel Carlson - October 2, 2020

Front Page

Muscle Maker Grill Opens Their Second College Campus Location in Virginia

Daniel Carlson - October 1, 2020

Front Page

Trade Alert, October 1, 2020

Daniel Carlson - October 1, 2020

Front Page

Provention Bio Files Clinical Module for Teplizumab for the Delay or...

Daniel Carlson - October 1, 2020

Fortress Bio

Mustang Bio Announces First Patient Dosed in Multicenter Phase 1/2 Clinical...

Daniel Carlson - October 1, 2020

Front Page

Cabral Gold Reports Channel Sample Results of 5.3m @ 24.0 g/t...

Daniel Carlson - September 30, 2020

Front Page

WiSA Introduces SoundSend Home Cinema Audio Transmitter to Instantly Connect 100’s...

Daniel Carlson - September 29, 2020

Front Page

Making Our Case For ParkerVision

Daniel Carlson - September 28, 2020

Front Page

ParkerVision Files Against Hisense for Patent Infringement

Daniel Carlson - September 28, 2020

Fortress Bio

Wrapping Up A Chaotic Week

Daniel Carlson - September 26, 2020

Front Page

Dyadic and VTT Are Developing an Efficient New Production Method for...

Daniel Carlson - September 24, 2020

Front Page

Muscle Maker Grill Opens Their First of Four College Campus Locations...

Daniel Carlson - September 24, 2020

Front Page

Cabral Gold Identifies New High-Grade Veins and Adds Second Drill Rig...

Daniel Carlson - September 24, 2020

Front Page

TFF Pharmaceuticals Comments on Animal Studies in the Development of High...

Daniel Carlson - September 24, 2020

Front Page

World’s First WiSA Ready™ 4K UHD Smart Projector Developed by LG...

Daniel Carlson - September 22, 2020

Anixa

Anixa’s Breast Cancer Vaccine; A Conversation With Dr. Vince Tuohy

Daniel Carlson - September 22, 2020

Front Page

Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer...

Daniel Carlson - September 22, 2020

Front Page

LexaGene’s CEO Provides Video Message on Company’s Progress and Announces Appointment...

Daniel Carlson - September 21, 2020

Anixa

West Bound and Down

Daniel Carlson - September 19, 2020

Fortress Bio

Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab...

Daniel Carlson - September 17, 2020

Front Page

Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug...

Daniel Carlson - September 17, 2020

Front Page

LexaGene’s Covid-19 Diagnostic Readies For The FDA

Daniel Carlson - September 17, 2020

Front Page

Muscle Maker Grill Ghosting NYC With Two New Ghost Kitchens

Daniel Carlson - September 16, 2020

Front Page

INmune Bio, Inc. Awarded $2.9 Million NIH Small Business Innovation Research...

Daniel Carlson - September 16, 2020

Front Page

TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1...

Daniel Carlson - September 15, 2020

Fortress Bio

Fortress Biotech Announces Initiation of Phase 3 Studies of CAEL-101 in...

Daniel Carlson - September 14, 2020

Anixa

Under The Radar…Key Data-Points From The Last Week That Nobody Really...

Daniel Carlson - September 12, 2020

Front Page

Muscle Maker Grill Announces Pricing of $5.6 Million Follow-On Public Offering...

Daniel Carlson - September 11, 2020

Fortress Bio

Avenue Therapeutics Announces Publication of a Review of IV Tramadol

Daniel Carlson - September 9, 2020

Front Page

Ontrak Announces Full Exercise of Overallotment Option in Public Offering of...

Daniel Carlson - September 8, 2020

Atomera

Hello Fall!

Daniel Carlson - September 4, 2020

Front Page

INmune Bio, Inc. Announces Issuance of Patent from U.S. Patent &...

Daniel Carlson - September 3, 2020

Anixa

Is It Finally Time For Anixa to Shine?

Daniel Carlson - September 3, 2020

Front Page

What’s Next for TFF?

Daniel Carlson - September 3, 2020

Fortress Bio

Mustang Bio Announces Orphan Drug Designation for MB-107 for the Treatment...

Daniel Carlson - September 2, 2020

Front Page

INmune Bio, Inc. Announces FDA Acceptance of IND Application to Evaluate...

Daniel Carlson - September 1, 2020

Fortress Bio

Mustang Bio Announces Rare Pediatric Disease Designation for MB-207 for the...

Daniel Carlson - August 31, 2020

Anixa

Goodbye August (almost)…

Daniel Carlson - August 29, 2020

Fortress Bio

Fortress Biotech Announces Positive Topline Clinical Efficacy Results for CUTX-101, Copper...

Daniel Carlson - August 28, 2020

Fortress Bio

Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management

Daniel Carlson - August 28, 2020

Front Page

Muscle Maker Grill Adds Two Locations in Philadelphia to Their Growing...

Daniel Carlson - August 27, 2020

Lantern

Lantern Pharma Announces Upcoming Conference Presentations

Daniel Carlson - August 27, 2020

Front Page

Trading Blog, August 26th

Daniel Carlson - August 26, 2020

Front Page

WiSA Member SKYWORTH Launches Metz Sculpture 1 TV and Speakers Featuring...

Daniel Carlson - August 25, 2020

Front Page

Ontrak Announces Public Offering of Non-Convertible Perpetual Preferred Stock

Daniel Carlson - August 22, 2020

Front Page

Trading Blog, August 21st

Daniel Carlson - August 21, 2020

Fortress Bio

Mustang Bio Announces Rare Pediatric Disease Designation for MB-107 for the...

Daniel Carlson - August 17, 2020

Anixa

This Week at Tailwinds

Daniel Carlson - August 15, 2020

Front Page

Dyadic Announces Second Quarter 2020 Results and Highlights Recent Company Progress

Daniel Carlson - August 14, 2020

Front Page